文献速递衰弱、肌少症与跌倒老年慢病共病管理

粪便微生物移植治疗高龄复发艰难梭菌感染

Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients.
PubMed 文献 · J Am Geriatr Soc · 2023-07-17

回顾性单中心研究纳入2014至2022年43例≥85岁接受FMT的复发性CDI患者,中位年龄88岁,首次FMT成功率77%,重复FMT后总有效率88%,轻度不良事件25%,结论认为FMT在高龄患者中有效安全,衰弱评估有助于识别需重复治疗者。

要点

  • 高龄复发性CDI患者首次FMT成功率77%,重复后总有效率88%。
  • 治疗成功者CFS显著低于失败或需重复FMT者。
  • 轻度不良事件25%,无FMT或rCDI相关死亡。

核心结论

  • FMT对≥85岁复发性CDI患者有效且安全。
  • 衰弱和高共病不限制高龄患者使用FMT。
  • 衰弱评估可能有助于识别预后较差或需重复FMT的患者。

研究设计与样本

  • 回顾性单中心研究,纳入2014至2022年≥85岁接受FMT治疗rCDI的患者43例,中位年龄88岁。
  • 基线采用Charlson共病指数评估共病,临床衰弱量表评估衰弱。

主要发现

  • 首次FMT成功率为77%。
  • 首次FMT失败的10例中5例经重复FMT治愈,总有效率为88%。
  • 治疗成功者CFS显著低于FMT失败或接受重复FMT者(两者p均<0.01)。
  • 轻度不良事件发生于11例(25%)。
  • 首次操作后7天内发生1例死亡,与FMT或rCDI无关。

关键数值与推荐

  • 疗效定义为8周随访时CDI治愈。
  • 共病采用Charlson共病指数测量。
  • 衰弱采用临床衰弱量表测量。

临床怎么用

  • 对≥85岁复发性CDI患者可考虑FMT治疗。
  • 衰弱和高共病不应作为高龄患者FMT的排除因素。
  • 可用临床衰弱量表评估以识别需重复FMT或预后较差的高危患者。

局限性

  • 回顾性单中心设计。
  • 样本量较小(43例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older age is a well-known risk factor for recurrent and severe Clostridioides difficile infection (CDI). Fecal microbiota transplantation (FMT) is widely recognized as an effective and safe therapeutic option for the treatment of recurrent CDI (rCDI). However, the efficacy and safety of FMT for rCDI in very old patients are uncertain. This study evaluated the efficacy and safety of FMT in a group of very old subjects with rCDI, and the reliability of overall comorbidity and frailty assessment for identifying patients at higher risk of worse clinical outcomes. METHODS: This is a retrospective single-center study including patients ≥85 years undergoing FMT for rCDI between 2014 and 2022. Primary outcomes included efficacy of FMT, defined as cure of CDI at 8 week-follow-up, and safety evaluation. At baseline, comorbidity was measured with the Charlson Comorbidity Index (CCI). Frailty was measured with the Clinical Frailty Scale (CFS). RESULTS: Overall, 43 patients with a median age of 88 years underwent FMT by colonoscopy in the study period. The rate of first FMT success was 77%. Five of the 10 patients who failed the first FMT infusion were cured after repeat FMT, with an overall efficacy of 88%. In patients with successful treatment, the CFS was significantly lower compared to those who failed the FMT or underwent repeat FMT (p < 0.01 for both). Mild adverse events occurred in 11 patients (25%). One death, not related to FMT or rCDI, occurred within 7 days from the first procedure. CONCLUSIONS: FMT is effective and safe in very old patients. Frailty and high comorbidity do not limit use of FMT in these patients. Frailty assessment has potential to better identify patients at higher risk of worse outcomes or for repeat treatment with FMT.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Montalto M, Gallo A, Agnitelli MC, et al. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients. J Am Geriatr Soc. 2023. PMID: 37458581. doi:10.1111/jgs.18500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。